✦ LIBER ✦

Switching epoetin alfa and epoetin zeta in patients with Renal Anemia on Dialysis: Posthoc analysis

✍ Scribed by Andrzej Więcek; Islah Ahmed; Paul Scigalla; Rossen Koytchev

Book ID: 107648704
Publisher: Springer Healthcare Communications
Year: 2010
Tongue: English
Weight: 266 KB
Volume: 27
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-010-0080-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dialysis patients treated with Epoetin a

Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial

✍ Paul A. KEOWN; David N. CHURCHILL; Melanie POULIN-COSTELLO; Lei LEI; Sandeep GAN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Impact of epoetin alfa on clinical end p

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

✍ Jones, Michael; Ibels, Lloyd; Schenkel, Brad; Zagari, Martin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB

Hemoglobin Variability with Extended Dos

Hemoglobin Variability with Extended Dosing of Epoetin Alfa in Patients with Chronic Kidney Disease and Not on Dialysis

✍ Robert A. Bailey; Tracy McGowan; K. Linda Tang; Wayne K. Langholff; Keith C. Lan 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 136 KB 👁 2 views

Regarding impact of epoetin alfa on clin

Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

✍ TONELLI, MARCELLO; OWEN, WILLIAM F; JINDAL, KAILASH; WINKELMAYER, WOLFGANG C; MA 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

133: Hematologic Outcomes and Dosing Pat

133: Hematologic Outcomes and Dosing Patterns in Anemic Patients With Pre-Dialysis Chronic Kidney Disease (CKD) Switching From Darbepoetin Alfa (DARB) to Epoetin Alfa (EPO)

✍ Claudia Hura; James Jackson; Orsolya Lunacsek; Robert A. Bailey; R. Scott McKenz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB

PCN8 A COST-CONSEQUENCE ANALYSIS OF DARB

PCN8 A COST-CONSEQUENCE ANALYSIS OF DARBEPOETIN ALFA ADMINISTERED EVERY 3 WEEKS (Q3W_DA) COMPARED TO WEEKLY EPOETIN ALFA (QW_EA) OR EPOETIN BETA (QW_EB) IN PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA (CIA): THE ITALIAN CASE

✍ G Esposito; M Lamotte; L Annemans; A Bracco 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB